RNAZ logo

TransCode Therapeutics (RNAZ) Enterprise Value

Enterprise Value

-$1.02 M
-$76.58 K-8.12%

Wed, 12 Mar 2025 23:59:57 GMT


Summary


Performance

RNAZ Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherRNAZvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

RNAZ Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-8.1%-9.8%-9.8%
1 m1 month-118.0%-90.5%-90.5%
3 m3 months-130.9%-86.0%-86.0%
6 m6 months-138.6%-83.9%-87.9%
ytdytd-263.8%-70.0%-70.0%
1 y1 year+74.1%+11.9%-94.9%
5 y5 years---

RNAZ Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-118.0%-$1 M+0.7%
3 m3-month$6.17 M-116.5%-$1 M+0.7%
6 m6-month$11 M-109.2%-$1 M+0.7%
1 y1-year$11 M-109.2%-$4 M+74.1%
3 y3-year$23 M-104.4%-$6 M+82.5%
5 y5-year$87 M-101.2%-$6 M+82.5%
alltimeall time$87 M-101.2%-$6 M+82.5%

TransCode Therapeutics Enterprise Value History

DateValue
2025
-$1.02 M(-263.8%)
2024
$622.79 K(-65.8%)
DateValue
2023
$1.82 M(-53.5%)
2022
$3.92 M(-69.2%)
2021
$12.70 M

FAQ

  • What is TransCode Therapeutics enterprise value?
  • What is the all time high enterprise value for TransCode Therapeutics?
  • What is RNAZ enterprise value year-to-date change?
  • What is TransCode Therapeutics enterprise value year-on-year change?

What is TransCode Therapeutics enterprise value?

The current enterprise value of RNAZ is -$1.02 M

What is the all time high enterprise value for TransCode Therapeutics?

TransCode Therapeutics all-time high enterprise value is $87.19 M

What is RNAZ enterprise value year-to-date change?

TransCode Therapeutics enterprise value has changed by -$1.64 M (-263.82%) since the beginning of the year

What is TransCode Therapeutics enterprise value year-on-year change?

Over the past year, RNAZ enterprise value has changed by +$2.93 M (+74.14%)